Stocks · Health care · Pharmaceutical Preparations

Serina Therapeutics, Inc.

SER Clue Score38
United States Fiscal year ends December CIK 0001708599 Results filed 13 Aug 2026

What the insiders did Net buying

By person

8 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Randall Moreadith
Chief Scientific Officer
—
$386.16K (23) scheduled
−$386.16K
0
$0.00
—
Karen J Wilson
Director
$54.75K (4)
—
+$54.75K
10,100
$20.50K
—
Richard Peter Marshall
Director
$20.10K (1)
—
+$20.10K
12,183
$24.73K
—
Stephen K. Brannan
Director
$2.03K (1)
—
+$2.03K
1,000
$2.03K
—
Jay Venkatesan
Director
$1.05K (1)
—
+$1.05K
232,294
$471.56K
—
Gregory Bailey
Director
—
—
—
8,564,382
$17.39M
+13,413%
Juvenescence Ltd entity
10% owner
—
—
—
3,267,188
$6.63M
+44.1%
Steven A Ledger
Chief Executive Officer
—
—
—
10,100
$20.50K
—

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 9,932,215 to 25,400,473 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.